Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors : Design, synthesis, biological activities, and mechanism of action
Identifieur interne : 004428 ( Main/Curation ); précédent : 004427; suivant : 004429Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors : Design, synthesis, biological activities, and mechanism of action
Auteurs : Roberto Di Santo [Italie] ; Roberta Costi [Italie] ; Alessandra Roux [Italie] ; Marino Artico [Italie] ; Antonio Lavecchia [Italie] ; Luciana Marinelli [Italie] ; Ettore Novellino [Italie] ; Lucia Palmisano [Italie] ; Mauro Andreotti [Italie] ; Roberta Amici [Italie] ; Clementina Maria Galluzzo [Italie] ; Lucia Nencioni [Italie] ; Anna Teresa Palamara [Italie] ; Yves Pommier [États-Unis] ; Christophe Marchand [États-Unis]Source :
- Journal of medicinal chemistry : (Print) [ 0022-2623 ] ; 2006.
Descripteurs français
- KwdFr :
- ADN viral (), Conception de médicament, Cétoacides (), Cétoacides (pharmacologie), Cétoacides (synthèse chimique), Domaine catalytique, Humains, Hydroxy-butyrates (), Hydroxy-butyrates (pharmacologie), Hydroxy-butyrates (synthèse chimique), Inhibiteurs de l'intégrase du VIH (), Inhibiteurs de l'intégrase du VIH (pharmacologie), Inhibiteurs de l'intégrase du VIH (synthèse chimique), Intégrase du VIH (), Intégrase du VIH (métabolisme), Liaison aux protéines, Lignée cellulaire, Modèles moléculaires, Quinolinone (), Quinolinone (pharmacologie), Quinolinone (synthèse chimique), Relation structure-activité, Structure tertiaire des protéines, VIH-1 (Virus de l'Immunodéficience Humaine de type 1) ().
- MESH :
- métabolisme : Intégrase du VIH.
- pharmacologie : Cétoacides, Hydroxy-butyrates, Inhibiteurs de l'intégrase du VIH, Quinolinone.
- synthèse chimique : Cétoacides, Hydroxy-butyrates, Inhibiteurs de l'intégrase du VIH, Quinolinone.
- Pascal (Inist)
- ADN viral, Conception de médicament, Cétoacide, Cétoacides, Dicétone, Domaine catalytique, Humains, Hydroxy-butyrates, Inhibiteurs de l'intégrase du VIH, Intégrase du VIH, Liaison aux protéines, Lignée cellulaire, Modèles moléculaires, Quinolinone, Relation structure-activité, Structure tertiaire des protéines, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Virus HIV1, Synthèse chimique, Relation structure activité, Mécanisme action, Quinolone dérivé, Cétoénol, Hydroxyacide, Acide carboxylique, Hétérocycle azote, Composé bicyclique, Composé aromatique, Modèle moléculaire, Complexe enzyme inhibiteur, Mode liaison, In vitro, Inhibiteur enzyme, Antiviral, Modélisation, Nucleotidyltransferases, Inhibiteur integrase, Quinoléine-3,6-dibut-2-énoïque acide(1-benzyl-1,4-dihydro-α-hydroxy-γ,γ,4-trioxo), Integrase.
English descriptors
- KwdEn :
- Antiviral, Aromatic compound, Bicyclic compound, Binding mode, Carboxylic acid, Catalytic Domain, Cell Line, Chemical synthesis, DNA, Viral (chemistry), Diketone, Drug Design, Enzyme inhibitor, HIV Integrase (chemistry), HIV Integrase (metabolism), HIV Integrase Inhibitors (chemical synthesis), HIV Integrase Inhibitors (chemistry), HIV Integrase Inhibitors (pharmacology), HIV-1 (drug effects), HIV-1 virus, Humans, Hydroxyacid, Hydroxybutyrates (chemical synthesis), Hydroxybutyrates (chemistry), Hydroxybutyrates (pharmacology), In vitro, Inhibitor enzyme complex, Keto Acids (chemical synthesis), Keto Acids (chemistry), Keto Acids (pharmacology), Ketoacid, Ketoenol, Mechanism of action, Modeling, Models, Molecular, Molecular model, Nitrogen heterocycle, Nucleotidyltransferases, Protein Binding, Protein Structure, Tertiary, Quinolone derivatives, Quinolones (chemical synthesis), Quinolones (chemistry), Quinolones (pharmacology), Structure activity relation, Structure-Activity Relationship.
- MESH :
- chemical , chemical synthesis : HIV Integrase Inhibitors, Hydroxybutyrates, Keto Acids, Quinolones.
- chemical , chemistry : DNA, Viral, HIV Integrase, HIV Integrase Inhibitors, Hydroxybutyrates, Keto Acids, Quinolones.
- chemical , metabolism : HIV Integrase.
- chemical , pharmacology : HIV Integrase Inhibitors, Hydroxybutyrates, Keto Acids, Quinolones.
- drug effects : HIV-1.
- Catalytic Domain, Cell Line, Drug Design, Humans, Models, Molecular, Protein Binding, Protein Structure, Tertiary, Structure-Activity Relationship.
Abstract
The virally encoded integrase protein is an essential enzyme in the life cycle of the HIV-1 virus and represents an attractive and validated target in the development of therapeutics against HIV infection. Drugs that selectively inhibit this enzyme, when used in combination with inhibitors of reverse transcriptase and protease, are believed to be highly effective in suppressing the viral replication. Among the HIV-1 integrase inhibitors, the /3-diketo acids (DKAs) represent a major lead for anti-HIV-1 drug development. In this study, novel bifunctional quinolonyl diketo acid derivatives were designed, synthesized, and tested for their inhibitory ability against HIV-1 integrase. The compounds are potent inhibitors of integrase activity. Particularly, derivative 8 is a potent IN inhibitor for both steps of the reaction (3'-processing and strand transfer) and exhibits both high antiviral activity against HIV-1 infected cells and low cytotoxicity. Molecular modeling studies provide a plausible mechanism of action, which is consistent with ligand SARs and enzyme photo-cross-linking experiments.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000476
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000514
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000448
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :004649
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002309
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002309
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002087
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001419
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001419
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001419
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003F78
Links to Exploration step
Pascal:06-0380365Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors : Design, synthesis, biological activities, and mechanism of action</title>
<author><name sortKey="Di Santo, Roberto" sort="Di Santo, Roberto" uniqKey="Di Santo R" first="Roberto" last="Di Santo">Roberto Di Santo</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Costi, Roberta" sort="Costi, Roberta" uniqKey="Costi R" first="Roberta" last="Costi">Roberta Costi</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roux, Alessandra" sort="Roux, Alessandra" uniqKey="Roux A" first="Alessandra" last="Roux">Alessandra Roux</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Artico, Marino" sort="Artico, Marino" uniqKey="Artico M" first="Marino" last="Artico">Marino Artico</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lavecchia, Antonio" sort="Lavecchia, Antonio" uniqKey="Lavecchia A" first="Antonio" last="Lavecchia">Antonio Lavecchia</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marinelli, Luciana" sort="Marinelli, Luciana" uniqKey="Marinelli L" first="Luciana" last="Marinelli">Luciana Marinelli</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Novellino, Ettore" sort="Novellino, Ettore" uniqKey="Novellino E" first="Ettore" last="Novellino">Ettore Novellino</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Palmisano, Lucia" sort="Palmisano, Lucia" uniqKey="Palmisano L" first="Lucia" last="Palmisano">Lucia Palmisano</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Andreotti, Mauro" sort="Andreotti, Mauro" uniqKey="Andreotti M" first="Mauro" last="Andreotti">Mauro Andreotti</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Amici, Roberta" sort="Amici, Roberta" uniqKey="Amici R" first="Roberta" last="Amici">Roberta Amici</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Galluzzo, Clementina Maria" sort="Galluzzo, Clementina Maria" uniqKey="Galluzzo C" first="Clementina Maria" last="Galluzzo">Clementina Maria Galluzzo</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nencioni, Lucia" sort="Nencioni, Lucia" uniqKey="Nencioni L" first="Lucia" last="Nencioni">Lucia Nencioni</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Istituto cli Microbiologia, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Palamara, Anna Teresa" sort="Palamara, Anna Teresa" uniqKey="Palamara A" first="Anna Teresa" last="Palamara">Anna Teresa Palamara</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Istituto cli Microbiologia, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pommier, Yves" sort="Pommier, Yves" uniqKey="Pommier Y" first="Yves" last="Pommier">Yves Pommier</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute Building 37. Room 5068, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892-4255</s2>
<s3>USA</s3>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, Maryland 20892-4255</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marchand, Christophe" sort="Marchand, Christophe" uniqKey="Marchand C" first="Christophe" last="Marchand">Christophe Marchand</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute Building 37. Room 5068, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892-4255</s2>
<s3>USA</s3>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, Maryland 20892-4255</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0380365</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0380365 INIST</idno>
<idno type="RBID">Pascal:06-0380365</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000476</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000514</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000448</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000448</idno>
<idno type="wicri:doubleKey">0022-2623:2006:Di Santo R:novel:bifunctional:quinolonyl</idno>
<idno type="wicri:Area/Main/Merge">004649</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16539381</idno>
<idno type="wicri:Area/PubMed/Corpus">002309</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002309</idno>
<idno type="wicri:Area/PubMed/Curation">002309</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002309</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002087</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002087</idno>
<idno type="wicri:Area/Ncbi/Merge">001419</idno>
<idno type="wicri:Area/Ncbi/Curation">001419</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001419</idno>
<idno type="wicri:doubleKey">0022-2623:2006:Di Santo R:novel:bifunctional:quinolonyl</idno>
<idno type="wicri:Area/Main/Merge">003F78</idno>
<idno type="wicri:Area/Main/Curation">004428</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors : Design, synthesis, biological activities, and mechanism of action</title>
<author><name sortKey="Di Santo, Roberto" sort="Di Santo, Roberto" uniqKey="Di Santo R" first="Roberto" last="Di Santo">Roberto Di Santo</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Costi, Roberta" sort="Costi, Roberta" uniqKey="Costi R" first="Roberta" last="Costi">Roberta Costi</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roux, Alessandra" sort="Roux, Alessandra" uniqKey="Roux A" first="Alessandra" last="Roux">Alessandra Roux</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Artico, Marino" sort="Artico, Marino" uniqKey="Artico M" first="Marino" last="Artico">Marino Artico</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lavecchia, Antonio" sort="Lavecchia, Antonio" uniqKey="Lavecchia A" first="Antonio" last="Lavecchia">Antonio Lavecchia</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marinelli, Luciana" sort="Marinelli, Luciana" uniqKey="Marinelli L" first="Luciana" last="Marinelli">Luciana Marinelli</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Novellino, Ettore" sort="Novellino, Ettore" uniqKey="Novellino E" first="Ettore" last="Novellino">Ettore Novellino</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Palmisano, Lucia" sort="Palmisano, Lucia" uniqKey="Palmisano L" first="Lucia" last="Palmisano">Lucia Palmisano</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Andreotti, Mauro" sort="Andreotti, Mauro" uniqKey="Andreotti M" first="Mauro" last="Andreotti">Mauro Andreotti</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Amici, Roberta" sort="Amici, Roberta" uniqKey="Amici R" first="Roberta" last="Amici">Roberta Amici</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Galluzzo, Clementina Maria" sort="Galluzzo, Clementina Maria" uniqKey="Galluzzo C" first="Clementina Maria" last="Galluzzo">Clementina Maria Galluzzo</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nencioni, Lucia" sort="Nencioni, Lucia" uniqKey="Nencioni L" first="Lucia" last="Nencioni">Lucia Nencioni</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Istituto cli Microbiologia, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Palamara, Anna Teresa" sort="Palamara, Anna Teresa" uniqKey="Palamara A" first="Anna Teresa" last="Palamara">Anna Teresa Palamara</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Istituto cli Microbiologia, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pommier, Yves" sort="Pommier, Yves" uniqKey="Pommier Y" first="Yves" last="Pommier">Yves Pommier</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute Building 37. Room 5068, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892-4255</s2>
<s3>USA</s3>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, Maryland 20892-4255</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marchand, Christophe" sort="Marchand, Christophe" uniqKey="Marchand C" first="Christophe" last="Marchand">Christophe Marchand</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute Building 37. Room 5068, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892-4255</s2>
<s3>USA</s3>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, Maryland 20892-4255</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Aromatic compound</term>
<term>Bicyclic compound</term>
<term>Binding mode</term>
<term>Carboxylic acid</term>
<term>Catalytic Domain</term>
<term>Cell Line</term>
<term>Chemical synthesis</term>
<term>DNA, Viral (chemistry)</term>
<term>Diketone</term>
<term>Drug Design</term>
<term>Enzyme inhibitor</term>
<term>HIV Integrase (chemistry)</term>
<term>HIV Integrase (metabolism)</term>
<term>HIV Integrase Inhibitors (chemical synthesis)</term>
<term>HIV Integrase Inhibitors (chemistry)</term>
<term>HIV Integrase Inhibitors (pharmacology)</term>
<term>HIV-1 (drug effects)</term>
<term>HIV-1 virus</term>
<term>Humans</term>
<term>Hydroxyacid</term>
<term>Hydroxybutyrates (chemical synthesis)</term>
<term>Hydroxybutyrates (chemistry)</term>
<term>Hydroxybutyrates (pharmacology)</term>
<term>In vitro</term>
<term>Inhibitor enzyme complex</term>
<term>Keto Acids (chemical synthesis)</term>
<term>Keto Acids (chemistry)</term>
<term>Keto Acids (pharmacology)</term>
<term>Ketoacid</term>
<term>Ketoenol</term>
<term>Mechanism of action</term>
<term>Modeling</term>
<term>Models, Molecular</term>
<term>Molecular model</term>
<term>Nitrogen heterocycle</term>
<term>Nucleotidyltransferases</term>
<term>Protein Binding</term>
<term>Protein Structure, Tertiary</term>
<term>Quinolone derivatives</term>
<term>Quinolones (chemical synthesis)</term>
<term>Quinolones (chemistry)</term>
<term>Quinolones (pharmacology)</term>
<term>Structure activity relation</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ADN viral ()</term>
<term>Conception de médicament</term>
<term>Cétoacides ()</term>
<term>Cétoacides (pharmacologie)</term>
<term>Cétoacides (synthèse chimique)</term>
<term>Domaine catalytique</term>
<term>Humains</term>
<term>Hydroxy-butyrates ()</term>
<term>Hydroxy-butyrates (pharmacologie)</term>
<term>Hydroxy-butyrates (synthèse chimique)</term>
<term>Inhibiteurs de l'intégrase du VIH ()</term>
<term>Inhibiteurs de l'intégrase du VIH (pharmacologie)</term>
<term>Inhibiteurs de l'intégrase du VIH (synthèse chimique)</term>
<term>Intégrase du VIH ()</term>
<term>Intégrase du VIH (métabolisme)</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Modèles moléculaires</term>
<term>Quinolinone ()</term>
<term>Quinolinone (pharmacologie)</term>
<term>Quinolinone (synthèse chimique)</term>
<term>Relation structure-activité</term>
<term>Structure tertiaire des protéines</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>HIV Integrase Inhibitors</term>
<term>Hydroxybutyrates</term>
<term>Keto Acids</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>DNA, Viral</term>
<term>HIV Integrase</term>
<term>HIV Integrase Inhibitors</term>
<term>Hydroxybutyrates</term>
<term>Keto Acids</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>HIV Integrase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>HIV Integrase Inhibitors</term>
<term>Hydroxybutyrates</term>
<term>Keto Acids</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>HIV-1</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Intégrase du VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Cétoacides</term>
<term>Hydroxy-butyrates</term>
<term>Inhibiteurs de l'intégrase du VIH</term>
<term>Quinolinone</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Cétoacides</term>
<term>Hydroxy-butyrates</term>
<term>Inhibiteurs de l'intégrase du VIH</term>
<term>Quinolinone</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Catalytic Domain</term>
<term>Cell Line</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Models, Molecular</term>
<term>Protein Binding</term>
<term>Protein Structure, Tertiary</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>ADN viral</term>
<term>Conception de médicament</term>
<term>Cétoacide</term>
<term>Cétoacides</term>
<term>Dicétone</term>
<term>Domaine catalytique</term>
<term>Humains</term>
<term>Hydroxy-butyrates</term>
<term>Inhibiteurs de l'intégrase du VIH</term>
<term>Intégrase du VIH</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Modèles moléculaires</term>
<term>Quinolinone</term>
<term>Relation structure-activité</term>
<term>Structure tertiaire des protéines</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
<term>Virus HIV1</term>
<term>Synthèse chimique</term>
<term>Relation structure activité</term>
<term>Mécanisme action</term>
<term>Quinolone dérivé</term>
<term>Cétoénol</term>
<term>Hydroxyacide</term>
<term>Acide carboxylique</term>
<term>Hétérocycle azote</term>
<term>Composé bicyclique</term>
<term>Composé aromatique</term>
<term>Modèle moléculaire</term>
<term>Complexe enzyme inhibiteur</term>
<term>Mode liaison</term>
<term>In vitro</term>
<term>Inhibiteur enzyme</term>
<term>Antiviral</term>
<term>Modélisation</term>
<term>Nucleotidyltransferases</term>
<term>Inhibiteur integrase</term>
<term>Quinoléine-3,6-dibut-2-énoïque acide(1-benzyl-1,4-dihydro-α-hydroxy-γ,γ,4-trioxo)</term>
<term>Integrase</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The virally encoded integrase protein is an essential enzyme in the life cycle of the HIV-1 virus and represents an attractive and validated target in the development of therapeutics against HIV infection. Drugs that selectively inhibit this enzyme, when used in combination with inhibitors of reverse transcriptase and protease, are believed to be highly effective in suppressing the viral replication. Among the HIV-1 integrase inhibitors, the /3-diketo acids (DKAs) represent a major lead for anti-HIV-1 drug development. In this study, novel bifunctional quinolonyl diketo acid derivatives were designed, synthesized, and tested for their inhibitory ability against HIV-1 integrase. The compounds are potent inhibitors of integrase activity. Particularly, derivative 8 is a potent IN inhibitor for both steps of the reaction (3'-processing and strand transfer) and exhibits both high antiviral activity against HIV-1 infected cells and low cytotoxicity. Molecular modeling studies provide a plausible mechanism of action, which is consistent with ligand SARs and enzyme photo-cross-linking experiments.</div>
</front>
</TEI>
<double idat="0022-2623:2006:Di Santo R:novel:bifunctional:quinolonyl"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors : Design, synthesis, biological activities, and mechanism of action</title>
<author><name sortKey="Di Santo, Roberto" sort="Di Santo, Roberto" uniqKey="Di Santo R" first="Roberto" last="Di Santo">Roberto Di Santo</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Costi, Roberta" sort="Costi, Roberta" uniqKey="Costi R" first="Roberta" last="Costi">Roberta Costi</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roux, Alessandra" sort="Roux, Alessandra" uniqKey="Roux A" first="Alessandra" last="Roux">Alessandra Roux</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Artico, Marino" sort="Artico, Marino" uniqKey="Artico M" first="Marino" last="Artico">Marino Artico</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lavecchia, Antonio" sort="Lavecchia, Antonio" uniqKey="Lavecchia A" first="Antonio" last="Lavecchia">Antonio Lavecchia</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marinelli, Luciana" sort="Marinelli, Luciana" uniqKey="Marinelli L" first="Luciana" last="Marinelli">Luciana Marinelli</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Novellino, Ettore" sort="Novellino, Ettore" uniqKey="Novellino E" first="Ettore" last="Novellino">Ettore Novellino</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Palmisano, Lucia" sort="Palmisano, Lucia" uniqKey="Palmisano L" first="Lucia" last="Palmisano">Lucia Palmisano</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Andreotti, Mauro" sort="Andreotti, Mauro" uniqKey="Andreotti M" first="Mauro" last="Andreotti">Mauro Andreotti</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Amici, Roberta" sort="Amici, Roberta" uniqKey="Amici R" first="Roberta" last="Amici">Roberta Amici</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Galluzzo, Clementina Maria" sort="Galluzzo, Clementina Maria" uniqKey="Galluzzo C" first="Clementina Maria" last="Galluzzo">Clementina Maria Galluzzo</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nencioni, Lucia" sort="Nencioni, Lucia" uniqKey="Nencioni L" first="Lucia" last="Nencioni">Lucia Nencioni</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Istituto cli Microbiologia, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Palamara, Anna Teresa" sort="Palamara, Anna Teresa" uniqKey="Palamara A" first="Anna Teresa" last="Palamara">Anna Teresa Palamara</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Istituto cli Microbiologia, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pommier, Yves" sort="Pommier, Yves" uniqKey="Pommier Y" first="Yves" last="Pommier">Yves Pommier</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute Building 37. Room 5068, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892-4255</s2>
<s3>USA</s3>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, Maryland 20892-4255</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marchand, Christophe" sort="Marchand, Christophe" uniqKey="Marchand C" first="Christophe" last="Marchand">Christophe Marchand</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute Building 37. Room 5068, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892-4255</s2>
<s3>USA</s3>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, Maryland 20892-4255</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0380365</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0380365 INIST</idno>
<idno type="RBID">Pascal:06-0380365</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000476</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000514</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000448</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000448</idno>
<idno type="wicri:doubleKey">0022-2623:2006:Di Santo R:novel:bifunctional:quinolonyl</idno>
<idno type="wicri:Area/Main/Merge">004649</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors : Design, synthesis, biological activities, and mechanism of action</title>
<author><name sortKey="Di Santo, Roberto" sort="Di Santo, Roberto" uniqKey="Di Santo R" first="Roberto" last="Di Santo">Roberto Di Santo</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Costi, Roberta" sort="Costi, Roberta" uniqKey="Costi R" first="Roberta" last="Costi">Roberta Costi</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roux, Alessandra" sort="Roux, Alessandra" uniqKey="Roux A" first="Alessandra" last="Roux">Alessandra Roux</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Artico, Marino" sort="Artico, Marino" uniqKey="Artico M" first="Marino" last="Artico">Marino Artico</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimenio di Studi Farmaceutici, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lavecchia, Antonio" sort="Lavecchia, Antonio" uniqKey="Lavecchia A" first="Antonio" last="Lavecchia">Antonio Lavecchia</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marinelli, Luciana" sort="Marinelli, Luciana" uniqKey="Marinelli L" first="Luciana" last="Marinelli">Luciana Marinelli</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Novellino, Ettore" sort="Novellino, Ettore" uniqKey="Novellino E" first="Ettore" last="Novellino">Ettore Novellino</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", via D. Montesano 49</s1>
<s2>80131 Napoli</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>80131 Napoli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Palmisano, Lucia" sort="Palmisano, Lucia" uniqKey="Palmisano L" first="Lucia" last="Palmisano">Lucia Palmisano</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Andreotti, Mauro" sort="Andreotti, Mauro" uniqKey="Andreotti M" first="Mauro" last="Andreotti">Mauro Andreotti</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Amici, Roberta" sort="Amici, Roberta" uniqKey="Amici R" first="Roberta" last="Amici">Roberta Amici</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Galluzzo, Clementina Maria" sort="Galluzzo, Clementina Maria" uniqKey="Galluzzo C" first="Clementina Maria" last="Galluzzo">Clementina Maria Galluzzo</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Dipartimento del Farmaco, Istituto Superiore di Sanità, Viale Regina Elena 299</s1>
<s2>00161 Roma</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nencioni, Lucia" sort="Nencioni, Lucia" uniqKey="Nencioni L" first="Lucia" last="Nencioni">Lucia Nencioni</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Istituto cli Microbiologia, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Palamara, Anna Teresa" sort="Palamara, Anna Teresa" uniqKey="Palamara A" first="Anna Teresa" last="Palamara">Anna Teresa Palamara</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Istituto cli Microbiologia, Università di Roma "La Sapienza", P. le A. Moro 5</s1>
<s2>00185 Roma</s2>
<s3>ITA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
<orgName type="university">Université de Rome « La Sapienza »</orgName>
<placeName><settlement type="city">Rome</settlement>
<region type="region" nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pommier, Yves" sort="Pommier, Yves" uniqKey="Pommier Y" first="Yves" last="Pommier">Yves Pommier</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute Building 37. Room 5068, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892-4255</s2>
<s3>USA</s3>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, Maryland 20892-4255</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marchand, Christophe" sort="Marchand, Christophe" uniqKey="Marchand C" first="Christophe" last="Marchand">Christophe Marchand</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute Building 37. Room 5068, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892-4255</s2>
<s3>USA</s3>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, Maryland 20892-4255</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Aromatic compound</term>
<term>Bicyclic compound</term>
<term>Binding mode</term>
<term>Carboxylic acid</term>
<term>Chemical synthesis</term>
<term>Diketone</term>
<term>Enzyme inhibitor</term>
<term>HIV-1 virus</term>
<term>Hydroxyacid</term>
<term>In vitro</term>
<term>Inhibitor enzyme complex</term>
<term>Ketoacid</term>
<term>Ketoenol</term>
<term>Mechanism of action</term>
<term>Modeling</term>
<term>Molecular model</term>
<term>Nitrogen heterocycle</term>
<term>Nucleotidyltransferases</term>
<term>Quinolone derivatives</term>
<term>Structure activity relation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Cétoacide</term>
<term>Dicétone</term>
<term>Virus HIV1</term>
<term>Synthèse chimique</term>
<term>Relation structure activité</term>
<term>Mécanisme action</term>
<term>Quinolone dérivé</term>
<term>Cétoénol</term>
<term>Hydroxyacide</term>
<term>Acide carboxylique</term>
<term>Hétérocycle azote</term>
<term>Composé bicyclique</term>
<term>Composé aromatique</term>
<term>Modèle moléculaire</term>
<term>Complexe enzyme inhibiteur</term>
<term>Mode liaison</term>
<term>In vitro</term>
<term>Inhibiteur enzyme</term>
<term>Antiviral</term>
<term>Modélisation</term>
<term>Nucleotidyltransferases</term>
<term>Inhibiteur integrase</term>
<term>Quinoléine-3,6-dibut-2-énoïque acide(1-benzyl-1,4-dihydro-α-hydroxy-γ,γ,4-trioxo)</term>
<term>Integrase</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The virally encoded integrase protein is an essential enzyme in the life cycle of the HIV-1 virus and represents an attractive and validated target in the development of therapeutics against HIV infection. Drugs that selectively inhibit this enzyme, when used in combination with inhibitors of reverse transcriptase and protease, are believed to be highly effective in suppressing the viral replication. Among the HIV-1 integrase inhibitors, the /3-diketo acids (DKAs) represent a major lead for anti-HIV-1 drug development. In this study, novel bifunctional quinolonyl diketo acid derivatives were designed, synthesized, and tested for their inhibitory ability against HIV-1 integrase. The compounds are potent inhibitors of integrase activity. Particularly, derivative 8 is a potent IN inhibitor for both steps of the reaction (3'-processing and strand transfer) and exhibits both high antiviral activity against HIV-1 infected cells and low cytotoxicity. Molecular modeling studies provide a plausible mechanism of action, which is consistent with ligand SARs and enzyme photo-cross-linking experiments.</div>
</front>
</TEI>
</INIST>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.</title>
<author><name sortKey="Di Santo, Roberto" sort="Di Santo, Roberto" uniqKey="Di Santo R" first="Roberto" last="Di Santo">Roberto Di Santo</name>
<affiliation wicri:level="1"><nlm:affiliation>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, and Istituto di Microbiologia, Università di Roma La Sapienza, P. le A. Moro 5, I-00185 Roma, Italy. roberto.disanto@uniroma1.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, and Istituto di Microbiologia, Università di Roma La Sapienza, P. le A. Moro 5, I-00185 Roma</wicri:regionArea>
<wicri:noRegion>I-00185 Roma</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Costi, Roberta" sort="Costi, Roberta" uniqKey="Costi R" first="Roberta" last="Costi">Roberta Costi</name>
</author>
<author><name sortKey="Roux, Alessandra" sort="Roux, Alessandra" uniqKey="Roux A" first="Alessandra" last="Roux">Alessandra Roux</name>
</author>
<author><name sortKey="Artico, Marino" sort="Artico, Marino" uniqKey="Artico M" first="Marino" last="Artico">Marino Artico</name>
</author>
<author><name sortKey="Lavecchia, Antonio" sort="Lavecchia, Antonio" uniqKey="Lavecchia A" first="Antonio" last="Lavecchia">Antonio Lavecchia</name>
</author>
<author><name sortKey="Marinelli, Luciana" sort="Marinelli, Luciana" uniqKey="Marinelli L" first="Luciana" last="Marinelli">Luciana Marinelli</name>
</author>
<author><name sortKey="Novellino, Ettore" sort="Novellino, Ettore" uniqKey="Novellino E" first="Ettore" last="Novellino">Ettore Novellino</name>
</author>
<author><name sortKey="Palmisano, Lucia" sort="Palmisano, Lucia" uniqKey="Palmisano L" first="Lucia" last="Palmisano">Lucia Palmisano</name>
</author>
<author><name sortKey="Andreotti, Mauro" sort="Andreotti, Mauro" uniqKey="Andreotti M" first="Mauro" last="Andreotti">Mauro Andreotti</name>
</author>
<author><name sortKey="Amici, Roberta" sort="Amici, Roberta" uniqKey="Amici R" first="Roberta" last="Amici">Roberta Amici</name>
</author>
<author><name sortKey="Galluzzo, Clementina Maria" sort="Galluzzo, Clementina Maria" uniqKey="Galluzzo C" first="Clementina Maria" last="Galluzzo">Clementina Maria Galluzzo</name>
</author>
<author><name sortKey="Nencioni, Lucia" sort="Nencioni, Lucia" uniqKey="Nencioni L" first="Lucia" last="Nencioni">Lucia Nencioni</name>
</author>
<author><name sortKey="Palamara, Anna Teresa" sort="Palamara, Anna Teresa" uniqKey="Palamara A" first="Anna Teresa" last="Palamara">Anna Teresa Palamara</name>
</author>
<author><name sortKey="Pommier, Yves" sort="Pommier, Yves" uniqKey="Pommier Y" first="Yves" last="Pommier">Yves Pommier</name>
</author>
<author><name sortKey="Marchand, Christophe" sort="Marchand, Christophe" uniqKey="Marchand C" first="Christophe" last="Marchand">Christophe Marchand</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16539381</idno>
<idno type="pmid">16539381</idno>
<idno type="doi">10.1021/jm0511583</idno>
<idno type="wicri:Area/PubMed/Corpus">002309</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002309</idno>
<idno type="wicri:Area/PubMed/Curation">002309</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002309</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002087</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002087</idno>
<idno type="wicri:Area/Ncbi/Merge">001419</idno>
<idno type="wicri:Area/Ncbi/Curation">001419</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001419</idno>
<idno type="wicri:doubleKey">0022-2623:2006:Di Santo R:novel:bifunctional:quinolonyl</idno>
<idno type="wicri:Area/Main/Merge">003F78</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.</title>
<author><name sortKey="Di Santo, Roberto" sort="Di Santo, Roberto" uniqKey="Di Santo R" first="Roberto" last="Di Santo">Roberto Di Santo</name>
<affiliation wicri:level="1"><nlm:affiliation>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, and Istituto di Microbiologia, Università di Roma La Sapienza, P. le A. Moro 5, I-00185 Roma, Italy. roberto.disanto@uniroma1.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, and Istituto di Microbiologia, Università di Roma La Sapienza, P. le A. Moro 5, I-00185 Roma</wicri:regionArea>
<wicri:noRegion>I-00185 Roma</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Costi, Roberta" sort="Costi, Roberta" uniqKey="Costi R" first="Roberta" last="Costi">Roberta Costi</name>
</author>
<author><name sortKey="Roux, Alessandra" sort="Roux, Alessandra" uniqKey="Roux A" first="Alessandra" last="Roux">Alessandra Roux</name>
</author>
<author><name sortKey="Artico, Marino" sort="Artico, Marino" uniqKey="Artico M" first="Marino" last="Artico">Marino Artico</name>
</author>
<author><name sortKey="Lavecchia, Antonio" sort="Lavecchia, Antonio" uniqKey="Lavecchia A" first="Antonio" last="Lavecchia">Antonio Lavecchia</name>
</author>
<author><name sortKey="Marinelli, Luciana" sort="Marinelli, Luciana" uniqKey="Marinelli L" first="Luciana" last="Marinelli">Luciana Marinelli</name>
</author>
<author><name sortKey="Novellino, Ettore" sort="Novellino, Ettore" uniqKey="Novellino E" first="Ettore" last="Novellino">Ettore Novellino</name>
</author>
<author><name sortKey="Palmisano, Lucia" sort="Palmisano, Lucia" uniqKey="Palmisano L" first="Lucia" last="Palmisano">Lucia Palmisano</name>
</author>
<author><name sortKey="Andreotti, Mauro" sort="Andreotti, Mauro" uniqKey="Andreotti M" first="Mauro" last="Andreotti">Mauro Andreotti</name>
</author>
<author><name sortKey="Amici, Roberta" sort="Amici, Roberta" uniqKey="Amici R" first="Roberta" last="Amici">Roberta Amici</name>
</author>
<author><name sortKey="Galluzzo, Clementina Maria" sort="Galluzzo, Clementina Maria" uniqKey="Galluzzo C" first="Clementina Maria" last="Galluzzo">Clementina Maria Galluzzo</name>
</author>
<author><name sortKey="Nencioni, Lucia" sort="Nencioni, Lucia" uniqKey="Nencioni L" first="Lucia" last="Nencioni">Lucia Nencioni</name>
</author>
<author><name sortKey="Palamara, Anna Teresa" sort="Palamara, Anna Teresa" uniqKey="Palamara A" first="Anna Teresa" last="Palamara">Anna Teresa Palamara</name>
</author>
<author><name sortKey="Pommier, Yves" sort="Pommier, Yves" uniqKey="Pommier Y" first="Yves" last="Pommier">Yves Pommier</name>
</author>
<author><name sortKey="Marchand, Christophe" sort="Marchand, Christophe" uniqKey="Marchand C" first="Christophe" last="Marchand">Christophe Marchand</name>
</author>
</analytic>
<series><title level="j">Journal of medicinal chemistry</title>
<idno type="ISSN">0022-2623</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Catalytic Domain</term>
<term>Cell Line</term>
<term>DNA, Viral (chemistry)</term>
<term>Drug Design</term>
<term>HIV Integrase (chemistry)</term>
<term>HIV Integrase (metabolism)</term>
<term>HIV Integrase Inhibitors (chemical synthesis)</term>
<term>HIV Integrase Inhibitors (chemistry)</term>
<term>HIV Integrase Inhibitors (pharmacology)</term>
<term>HIV-1 (drug effects)</term>
<term>Humans</term>
<term>Hydroxybutyrates (chemical synthesis)</term>
<term>Hydroxybutyrates (chemistry)</term>
<term>Hydroxybutyrates (pharmacology)</term>
<term>Keto Acids (chemical synthesis)</term>
<term>Keto Acids (chemistry)</term>
<term>Keto Acids (pharmacology)</term>
<term>Models, Molecular</term>
<term>Protein Binding</term>
<term>Protein Structure, Tertiary</term>
<term>Quinolones (chemical synthesis)</term>
<term>Quinolones (chemistry)</term>
<term>Quinolones (pharmacology)</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ADN viral ()</term>
<term>Conception de médicament</term>
<term>Cétoacides ()</term>
<term>Cétoacides (pharmacologie)</term>
<term>Cétoacides (synthèse chimique)</term>
<term>Domaine catalytique</term>
<term>Humains</term>
<term>Hydroxy-butyrates ()</term>
<term>Hydroxy-butyrates (pharmacologie)</term>
<term>Hydroxy-butyrates (synthèse chimique)</term>
<term>Inhibiteurs de l'intégrase du VIH ()</term>
<term>Inhibiteurs de l'intégrase du VIH (pharmacologie)</term>
<term>Inhibiteurs de l'intégrase du VIH (synthèse chimique)</term>
<term>Intégrase du VIH ()</term>
<term>Intégrase du VIH (métabolisme)</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Modèles moléculaires</term>
<term>Quinolinone ()</term>
<term>Quinolinone (pharmacologie)</term>
<term>Quinolinone (synthèse chimique)</term>
<term>Relation structure-activité</term>
<term>Structure tertiaire des protéines</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>HIV Integrase Inhibitors</term>
<term>Hydroxybutyrates</term>
<term>Keto Acids</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>DNA, Viral</term>
<term>HIV Integrase</term>
<term>HIV Integrase Inhibitors</term>
<term>Hydroxybutyrates</term>
<term>Keto Acids</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>HIV Integrase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>HIV Integrase Inhibitors</term>
<term>Hydroxybutyrates</term>
<term>Keto Acids</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>HIV-1</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Intégrase du VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Cétoacides</term>
<term>Hydroxy-butyrates</term>
<term>Inhibiteurs de l'intégrase du VIH</term>
<term>Quinolinone</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Cétoacides</term>
<term>Hydroxy-butyrates</term>
<term>Inhibiteurs de l'intégrase du VIH</term>
<term>Quinolinone</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Catalytic Domain</term>
<term>Cell Line</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Models, Molecular</term>
<term>Protein Binding</term>
<term>Protein Structure, Tertiary</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>ADN viral</term>
<term>Conception de médicament</term>
<term>Cétoacides</term>
<term>Domaine catalytique</term>
<term>Humains</term>
<term>Hydroxy-butyrates</term>
<term>Inhibiteurs de l'intégrase du VIH</term>
<term>Intégrase du VIH</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Modèles moléculaires</term>
<term>Quinolinone</term>
<term>Relation structure-activité</term>
<term>Structure tertiaire des protéines</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The virally encoded integrase protein is an essential enzyme in the life cycle of the HIV-1 virus and represents an attractive and validated target in the development of therapeutics against HIV infection. Drugs that selectively inhibit this enzyme, when used in combination with inhibitors of reverse transcriptase and protease, are believed to be highly effective in suppressing the viral replication. Among the HIV-1 integrase inhibitors, the beta-diketo acids (DKAs) represent a major lead for anti-HIV-1 drug development. In this study, novel bifunctional quinolonyl diketo acid derivatives were designed, synthesized, and tested for their inhibitory ability against HIV-1 integrase. The compounds are potent inhibitors of integrase activity. Particularly, derivative 8 is a potent IN inhibitor for both steps of the reaction (3'-processing and strand transfer) and exhibits both high antiviral activity against HIV-1 infected cells and low cytotoxicity. Molecular modeling studies provide a plausible mechanism of action, which is consistent with ligand SARs and enzyme photo-cross-linking experiments.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004428 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004428 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Curation |type= RBID |clé= Pascal:06-0380365 |texte= Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors : Design, synthesis, biological activities, and mechanism of action }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |